Gene Therapy Market
Gene Therapy Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Gene Therapy Market Size and Growth
Gene Therapy market research reports indicate a growing market with a size estimated at $3.1 billion in 2021, projected to increase to $13.2 billion by 2028.
Advancements in technology and increasing investment in research and development are driving market growth. Key players include Novartis, Bristol Myers Squibb, and Bluebird Bio.
Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Biogen
◍ Novartis
◍ Gilead Sciences
◍ Sarepta Therapeutics
◍ Alnylam Pharmaceuticals
◍ Amgen
◍ Spark Therapeutics
◍ Akcea Therapeutics
◍ bluebird bio
◍ Sunway Biotech
◍ SIBIONO
◍ AnGes
◍ Orchard Therapeutics
◍ Human Stem Cells Institute
The gene therapy market is highly competitive with companies like Biogen, Novartis, Gilead Sciences, and others actively involved in the development and commercialization of gene therapy products. These companies utilize gene therapy to treat various diseases such as rare genetic disorders, cancer, and neurological diseases, driving the growth of the market.
- Biogen: Sales revenue of $14.37 billion
- Novartis: Sales revenue of $51.9 billion
- Gilead Sciences: Sales revenue of $24.47 billion
- Sarepta Therapeutics: Sales revenue of $548.7 million
These companies contribute to the growth of the gene therapy market by investing in research and development, acquiring or partnering with other companies, and obtaining regulatory approvals for their gene therapy products.
Request Sample Report
Market Segmentation
By Application
Neurological Diseases
Cancer
Other
Request Sample Report
By Product
Viral Gene Therapy
Non-Viral Gene Therapy
Market Growth
Request Sample Report
$ X Billion USD
